DVCD AL denied for missing prior authorization by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for dvcd al are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Requires Prior Authorization for a Medical Device for Alcohol Use Disorder

Blue Cross Blue Shield plans require prior authorization (PA) for many durable medical devices and monitoring devices related to alcohol use disorder because these items are considered "non-routine" or involve ongoing clinical management. A PA-required denial simply means a coverage decision was made without the plan's advance sign-off — it does not mean the device is excluded from your benefit plan.

## Why This Denial Is Appealable

A retrospective PA denial — issued after the device was already prescribed or dispensed — is one of the most commonly overturned denial types. Under ERISA §503 and ACA §2719, the plan must conduct a full-and-fair review and cannot hold you to a procedural requirement if the urgency of your medical situation made advance authorization impractical. Additionally, if your prescriber attempted to obtain PA and BCBS failed to respond within the regulatory timeframe, coverage cannot be retroactively denied on that basis.

## Federal Appeal Framework

• Internal appeal: File within the deadline on your denial notice (commonly 180 days). Request the complete claim file and all utilization-management guidelines applied to your case.
• External review: Available after final internal denial or after the plan fails to decide within the required window. Expedited review is available if your condition is urgent. The standard external-review window is approximately four months from the final adverse determination.

## Concrete Appeal Steps

1. Confirm whether a PA request was ever submitted and, if so, obtain the reference number and any correspondence. 2. If no PA was submitted, explain in your appeal why timely PA was not practical (e.g., emergent clinical need, prescriber was unaware of requirement at time of ordering). 3. Obtain a retroactive PA request from your prescriber and submit it alongside the appeal — many BCBS plans accept concurrent retroactive PA + appeal filings. 4. Attach all clinical documentation demonstrating medical necessity (see below). 5. Cite any BCBS policy language requiring timely responses to PA requests — if the plan failed to respond within its own stated window, note that.

## Documentation to Gather

• Diagnosis confirmation: Chart notes establishing the diagnosis and medical indication for the device.
• Prior-treatment history: Records showing what treatments were tried before this device was recommended, with dates and outcomes.
• Clinical severity: Clinician documentation of the severity of the condition and the medical rationale for device use.
• Prescriber medical-necessity letter: A letter from the ordering clinician explaining the indication, the rationale for this device specifically, and confirmation that the use matches the FDA-cleared indication.
• PA submission records: Any portal confirmation numbers, fax confirmations, or phone-call logs if a PA was attempted.

## Criteria-Mapping Structure

Request BCBS's coverage criteria for this device category. For each criterion listed, provide a specific chart reference (date of visit, clinician name, exact language from the note) showing your case satisfies it. If a criterion references the FDA-approved labeling or a clinical guideline organization (such as ASAM — the American Society of Addiction Medicine), confirm your prescriber has documented that the prescribed use aligns with those guidelines.